SOURCE: The Scientist / Biotech360

May 07, 2007 08:00 ET

Can Biotechnology Save the Developing World?

Biotech360, a New Global Magazine for the Biotech Industry Launches and Explores the Question in Its Premiere Issue

BOSTON, MA -- (MARKET WIRE) -- May 7, 2007 -- Biotech360, a new quarterly magazine developed for the biotechnology community by the publishers of The Scientist, was launched today at the Biotechnology Industry Organization (BIO) annual meeting. The magazine, published quarterly, will reach an estimated 30,000 influential readers around the globe.

Biotech360's premiere issue focuses on the theme "how biotech is impacting the developing world." With two million people still dying every year from tuberculosis and the current vaccine considered inadequate at best, the world needs new therapies. The story describes the work of a team at Harvard University that believes that a new method of delivery for the vaccine could be the key to beating back TB. The issue also explores biofuels being developed in Kenya and the promise of, and obstacles faced by, genetically modified crops.

"The mission in creating Biotech360 was simple," says The Scientist Group Publisher Richard Gallagher: "To hold up a mirror to global biotechnological advances and policy discussions and offer our readers the most provocative and relevant stories."

Biotech360 delivers unconventional content and in-depth profiling of the people, culture and business in the biotech industry, in a sophisticated breakthrough design usually reserved for consumer publications. It provides a fresh perspective on the field, from experts on the inside and analysts on the outside. By covering topics that are transforming our health, our lives, and our world, Biotech360 offers a global view of the industry and helps promote dialogue among key opinion-leaders.

Prominent members of the biotech community are already making their voices heard through Biotech360. Ram Sasisekharan, professor of biological engineering and health sciences & technology at the Massachusetts Institute of Technology and a co-founder and director of Momenta Pharmaceuticals and Tempo Pharmaceuticals, gives his top tips on turning research into a start up. Greg Lucier, Invitrogen's CEO, calls on his colleagues in biotech to work together to encourage increases in federal funding for basic research, which would help academics and biotech companies.

"The key to Biotech360 arises from the delivery: instead of just giving news, it provides the background, including successes, failures, and conflicting opinions," says Biotech360's premiere issue editor Mike May. "It truly lets readers see how biotech operates from an on-the-ground perspective."

The Scientist, magazine of the life sciences, worked in partnership with Santa Cruz, Calif.-based Technology Vision Group, a trusted advisor to the world's leading life science companies and institutions, to develop the select Biotech360 readership. "Our primary target audience is global influencers in biotechnology," says The Scientist marketing director Leslie Schultz. "This publication reaches the leaders in the field -- from executives at small biotech firms and large pharma companies to venture capitalists, policymakers, lobbyists, entrepreneurial academics, and interested consumers."

Procter & Gamble Pharmaceuticals sponsored the premiere issue of Biotech360. "It was a pleasure to work with P&G, as they have a very interesting story to tell and see the value of a new, sophisticated global biotech magazine," says Jeremy Abbate, Director of Business Development for The Scientist. "While many people are familiar with their consumer brands, not many people know about their pharmaceutical division and their unique partnering model."


Biotech360, from the publishers of The Scientist, is a print and online magazine that delivers the in-depth profiling of the people, culture and business in the biotech industry. While embracing the hope and challenging the hype, we promise to illuminate the most pressing issues on the world landscape. Biotech360 provides insight and analysis for industry opinion leaders, academics, entrepreneurs, the venture capital and finance communities, and legislators, as well as interested, educated consumers around the world. For more information on Biotech360, visit


The Scientist, the magazine of the life sciences, has informed and entertained life science professionals around the world for the past 20 years. We provide innovative print and online coverage of the latest developments in the life sciences including trends in research, technology, news, business and careers. We reach the leading researchers in academia and industry that are interested in maintaining a broad view of the life sciences by reading insightful articles that are current, concise, accurate and entertaining. For more information about The Scientist, visit

Contact Information

  • For more information, please contact:
    Leslie Schultz
    The Scientist
    215-351-1660 x3001
    Email Contact